Corrigendum | Open Access
Corrigendum to “Pharmacological Basis for Use of Selaginella moellendorffii in Gouty Arthritis: Antihyperuricemic, Anti-Inflammatory, and Xanthine Oxidase Inhibition”
In the article titled “Pharmacological Basis for Use of Selaginella moellendorffii in Gouty Arthritis: Antihyperuricemic, Anti-Inflammatory, and Xanthine Oxidase Inhibition” , there was a missing grant number. Accordingly, the Acknowledgments section should be corrected as follows:
This work was funded by China Postdoctoral Science Foundation (2016M601237), the Natural Science Foundation Project (30470193), the Scientific Research Foundation Project of the Education Department of Hubei Province (Q20142007), Natural Science Foundation of Hubei Province (2013CFC055), and the Young Plan Project of Hubei University of Chinese Medicine (XJ2014KJ008).
- P. Zhao, K. Chen, G. Zhang, G. Deng, and J. Li, “Pharmacological basis for use of Selaginella moellendorffii in gouty arthritis: antihyperuricemic, anti-inflammatory, and xanthine oxidase inhibition,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, 10 pages, 2017.
Copyright © 2018 Ping Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.